Physician profile
Mohan K Cheema
NPI 1669570453
$1,996.58
in general payments reported to CMS, 2019-2025
16 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $332 · 2020: $307 · 2021: $425 · 2022: $168 · 2023: $391 · 2024: $254 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $765.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $764.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $943.71 | 2019-2024 | Trelegy Ellipta, Arexvy, Nucala |
| Pfizer INC. | $168.99 | 2019-2021 | |
| Inari Medical, INC. | $167.91 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Exact Sciences Corporation | $126.11 | 2023-2024 | Cologuard Collection Kit |
| Gilead Sciences, INC. | $125.00 | 2019 | |
| Ironwood Pharmaceuticals, INC | $107.34 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $76.94 | 2020-2022 | |
| Insmed, INC. | $75.68 | 2024-2025 | Arikayce, Brinsupri |
| Mallinckrodt Enterprises LLC | $37.65 | 2019 | |
| Electromed, INC. | $35.36 | 2025 | Smartvest |
| Takeda Pharmaceuticals U.S.A., INC. | $30.99 | 2023 | Glassia |
| Genzyme Corporation | $30.94 | 2025 | |
| Mylan Specialty L.P. | $21.17 | 2020 | |
| Merck Sharp & Dohme LLC | $17.94 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.32 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $13.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohan Cheema listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.